|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment | |||||
| Tradename impairment | |||||
| Long-lived assets impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other expenses, net | |||||
| Interest expense, net | |||||
| Other income, net | |||||
| Loss on extinguishment of debt | |||||
| Other adjustment to loan exit fee | |||||
| Total other expenses, net | |||||
| Loss before income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average shares used in computing net loss per share - basic | |||||
| Weighted average shares used in computing net loss per share - diluted | |||||
Loading...